Free Trial

Phreesia (PHR) Stock Forecast & Price Target

Phreesia logo
$24.28 -1.20 (-4.71%)
As of 03:48 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Phreesia - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
0
Buy
13

Based on 13 Wall Street analysts who have issued ratings for Phreesia in the last 12 months, the stock has a consensus rating of "Buy." Out of the 13 analysts, 12 have given a buy rating, and 1 has given a strong buy rating for PHR.

Consensus Price Target

$34.08
40.29% Upside
According to the 13 analysts' twelve-month price targets for Phreesia, the average price target is $34.08. The highest price target for PHR is $38.00, while the lowest price target for PHR is $30.00. The average price target represents a forecasted upside of 40.29% from the current price of $24.29.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for PHR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Phreesia and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PHR Analyst Ratings Over Time

TypeCurrent Forecast
9/12/24 to 9/12/25
1 Month Ago
8/13/24 to 8/13/25
3 Months Ago
6/14/24 to 6/14/25
1 Year Ago
9/13/23 to 9/12/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
10 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$34.08$32.27$31.64$30.23
Forecasted Upside40.29% Upside12.57% Upside21.75% Upside27.23% Upside
Consensus RatingBuyBuyBuyModerate Buy

PHR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PHR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Phreesia Stock vs. The Competition

TypePhreesiaMedical CompaniesS&P 500
Consensus Rating Score
3.08
2.78
2.53
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside33.89% Upside17,124.02% Upside9.66% Upside
News Sentiment Rating
Positive News

See Recent PHR News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/8/2025Citigroup
2 of 5 stars
 Reiterated RatingOutperform
9/8/2025DA Davidson
2 of 5 stars
Lucky Schreiner
Lucky Schreiner
Not Rated
UpgradeStrong-Buy
9/8/2025JMP Securities
3 of 5 stars
Silvan Tuerkcan
1 of 5 stars
Boost TargetMarket Outperform$30.00 ➝ $34.00+21.73%
9/5/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$35.00 ➝ $36.00+28.16%
9/5/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Set TargetOutperform$33.00+17.48%
9/5/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$34.00 ➝ $38.00+34.05%
9/5/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$29.00 ➝ $35.00+11.80%
9/5/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$33.00 ➝ $34.00+8.61%
9/3/2025Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$32.00+1.70%
8/27/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$36.00+16.71%
7/14/2025KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$28.00 ➝ $35.00+30.89%
1/8/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSector PerformOutperform$24.00 ➝ $32.00+18.56%
12/11/2024Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOutperform$34.00 ➝ $30.00+24.22%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$27.00 ➝ $28.00+17.60%
1/3/2024Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageOverweight$29.00+26.36%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:48 PM ET.


PHR Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Phreesia is $34.08, with a high forecast of $38.00 and a low forecast of $30.00.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last twelve months. There are currently 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" PHR shares.

According to analysts, Phreesia's stock has a predicted upside of 40.29% based on their 12-month stock forecasts.

Over the previous 90 days, Phreesia's stock had 2 upgrades by analysts.

Analysts like Phreesia more than other "medical" companies. The consensus rating for Phreesia is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PHR compares to other companies.


This page (NYSE:PHR) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners